Headquartered in Newburyport, MA Fiscal year ends December NASDAQ: UFPT ufpt.com
UFP Technologies, Inc. (Nasdaq: UFPT) is a contract development and manufacturing organization (CDMO). It provides comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products.
Its single-use and single-patient devices and components go into a wide range of medical products. End markets include robotic assisted surgery, patient beds and handling, infection control, cardiovascular, orthopedics and spine, and wound care.
The company reports MedTech (medical) and non-medical sales. MedTech is the main growth driver, and the company depends substantially on its two largest customers under supply agreements.
UFP grows both organically and through acquisitions. Recent acquisitions and investments include:
- TPI, acquired in 2025, which added injection molding capability.
- AJR, with operations in the U.S. and the Dominican Republic.
- DAS Medical, where capacity has been expanded.
The company is scaling manufacturing programs and facility expansions in the Dominican Republic. It is also pursuing further acquisitions supported by a planned expansion of its credit facility. Updated
Gross margin widened to 29.4% from 27.7% a year ago, turning 11.6% sales growth into a seventh straight earnings beat for the medical device contract manufacturer. MedTech sales rose 12.5%, undercutting the concentration worry while management expands its credit facility to chase larger acquisitions into 2027.
UFP Technologies, Inc. (Nasdaq: UFPT) is a contract development and manufacturing organization (CDMO). It provides comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products.
The Wall Street consensus 12-month price target for UFPT is $357.50.